Compare Divis Laboratories with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES IPCA LABS DIVIS LABORATORIES/
IPCA LABS
 
P/E (TTM) x 67.1 26.5 252.8% View Chart
P/BV x 14.8 5.7 259.1% View Chart
Dividend Yield % 0.4 0.4 102.1%  

Financials

 DIVIS LABORATORIES   IPCA LABS
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-21
IPCA LABS
Mar-21
DIVIS LABORATORIES/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs3,9132,456 159.4%   
Low Rs1,8241,371 133.0%   
Sales per share (Unadj.) Rs262.5423.3 62.0%  
Earnings per share (Unadj.) Rs74.790.6 82.5%  
Cash flow per share (Unadj.) Rs84.4107.1 78.8%  
Dividends per share (Unadj.) Rs20.008.00 250.0%  
Avg Dividend yield %0.70.4 166.8%  
Book value per share (Unadj.) Rs350.1370.6 94.5%  
Shares outstanding (eoy) m265.47126.85 209.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x10.94.5 241.7%   
Avg P/E ratio x38.421.1 181.6%  
P/CF ratio (eoy) x34.017.9 190.2%  
Price / Book Value ratio x8.25.2 158.7%  
Dividend payout %26.88.8 302.9%   
Avg Mkt Cap Rs m761,517242,728 313.7%   
No. of employees `000NANA-   
Total wages/salary Rs m8,25810,136 81.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m69,69453,699 129.8%  
Other income Rs m6261,292 48.4%   
Total revenues Rs m70,32054,991 127.9%   
Gross profit Rs m28,61214,812 193.2%  
Depreciation Rs m2,5562,092 122.2%   
Interest Rs m21123 17.1%   
Profit before tax Rs m26,66013,890 191.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8182,401 283.9%   
Profit after tax Rs m19,84311,488 172.7%  
Gross profit margin %41.127.6 148.8%  
Effective tax rate %25.617.3 147.9%   
Net profit margin %28.521.4 133.1%  
BALANCE SHEET DATA
Current assets Rs m67,90634,370 197.6%   
Current liabilities Rs m17,28411,331 152.5%   
Net working cap to sales %72.642.9 169.3%  
Current ratio x3.93.0 129.5%  
Inventory Days Days1049 19.6%  
Debtors Days Days8786 15,913.2%  
Net fixed assets Rs m45,96326,295 174.8%   
Share capital Rs m531254 209.3%   
"Free" reserves Rs m92,41546,763 197.6%   
Net worth Rs m92,94647,017 197.7%   
Long term debt Rs m0365 0.0%   
Total assets Rs m113,86960,664 187.7%  
Interest coverage x1,270.5114.2 1,112.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.9 69.1%   
Return on assets %17.419.1 91.1%  
Return on equity %21.324.4 87.4%  
Return on capital %28.729.6 97.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m027,172 0.0%   
Fx outflow Rs m07,949 0.0%   
Net fx Rs m019,223 0.0%   
CASH FLOW
From Operations Rs m19,46910,901 178.6%  
From Investments Rs m751-5,207 -14.4%  
From Financial Activity Rs m-349-3,058 11.4%  
Net Cashflow Rs m19,8722,636 753.8%  

Share Holding

Indian Promoters % 52.0 46.3 112.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.1 43.9 84.4%  
FIIs % 20.7 18.5 112.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 53.7 89.5%  
Shareholders   223,403 95,239 234.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   TYCHE INDUSTRIES  GENNEX LAB.  KIMIA BIOSCIENCES  TORRENT PHARMA  PHAARMASIA  



Today's Market

Sensex Down 400 Points, Nifty Below 18,100; Adani Ports & Titan Among Top Losers(10:30 am)

Asian share markets are lower today, extending falls on Wall Street as investors awaited a monetary policy decision from the Bank of Japan and European Central Bank (ECB) later in the day.

Related Views on News

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

IPCA LABS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of IPCA LABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of IPCA LABS. Also includes updates on the valuation of IPCA LABS.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY22); Net Profit Down 30.8% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, IPCA LABS has posted a net profit of Rs 3 bn (down 30.8% YoY). Sales on the other hand came in at Rs 16 bn (up 2.0% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

Up 31,500% in a Year! This Packaging Company Sheds its Penny Stock Status(Views On News)

Oct 18, 2021

What's driving the relentless rally in this packaging company?

Insider Alert! Promoters are Increasing their Stakes in these 5 Companies(Views On News)

Oct 19, 2021

Promoters of many small and mid-cap companies are raising their stakes since the last few quarters.

The One Company Riding the Auto Revolution Beyond EVs(Profit Hunter)

Oct 22, 2021

It's not just about batteries taking over the internal combustion engine. Bigger disruptive forces are coming along with electrification.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Oct 28, 2021 11:01 AM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - S.S.ORGANICS COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS